Calendar Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE
Stocks
US74365A1016
Pharmaceuticals
Upcoming events on Protalix Biotherapeutics Inc
No events available
Past events on Protalix Biotherapeutics Inc
| 12/08/2026 | Earnings presentation | 16:00 |
| 12/08/2026 | Earnings release - Q2 2026 | |
| 25/06/2026 | Annual General Meeting | 16:00 |
| 13/05/2026 | Earnings presentation | 16:00 |
| 13/05/2026 | Earnings release - Q1 2026 | |
| 18/03/2026 | Earnings presentation | 16:00 |
| 18/03/2026 | Earnings release - Annual 2025 | |
| 13/11/2025 | Earnings release - Q3 2025 | |
| 13/11/2025 | Earnings presentation | 17:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 65,5 64,0 2.41% | 53,4 53,9 -0.98% | 52,7 58,0 -9.03% | 79,8 | 68,2 | 68,8 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 10,5 11,5 -9.12% | 3,92 1,44 171.26% | -5,50 -0,83 -563.85% | 18,3 | 3,38 | 1,13 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8,57 9,56 -10.41% | 4,15 1,62 156.18% | -5,61 -0,48 -1061.08% | 18,9 | 4,82 | 1,71 |
|
Net income Million USD | Released Forecast Spread | 8,31 8,12 2.31% | 2,93 1,22 140.03% | -6,60 -0,75 -775.28% | 15,4 | 4,46 | 1,52 |
|
EPS USD | Released Forecast Spread | 0,09 0,11 -14.29% | 0,04 0,02 166.67% | -0,08 -0,01 -1500% | 0,19 | 0,06 | 0,02 |
| Announcement Date | 14/03/24 | 17/03/25 | 18/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 18,2 18,7 -2.81% | 10,1 21,6 -53.18% | 15,7 13,5 16.11% | 17,9 17,9 -0.08% | 9,12 14,4 -36.47% | 33,8 11,5 194.3% | 19,9 12,9 53.86% | 13,4 | 16,1 | 16,1 | 17,7 | 19,7 | 22,6 |
|
EBIT Million USD | Released Forecast Spread | 7,21 4,74 52.22% | 1,17 2,20 -46.65% | 2,13 4,25 -49.87% | -4,66 0,01 -34603.7% | 21,1 -1,42 1587.06% | 4,67 -1,32 454.48% | -4,07 | -3,40 | |||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7,32 4,90 49.26% | 0,66 2,53 -73.91% | 2,24 4,60 -51.28% | -4,78 0,35 -1468.48% | 21,1 -1,14 1951.23% | 4,86 -1,02 576.24% | -3,86 | -3,21 | |||||
|
Net income Million USD | Released Forecast Spread | 6,49 4,90 32.49% | 0,16 2,38 -93.1% | 2,36 4,44 -47% | -5,50 0,21 -2702.36% | 18,3 -1,01 1906.41% | 3,78 -0,96 491.8% | -3,67 | -3,05 | |||||
|
EPS USD | Released Forecast Spread | 0,09 0,07 28.57% | -0,05 0,08 -162.5% | 0,00 0,03 - | 0,03 0,06 -45.45% | -0,07 0,01 -1500% | 0,22 -0,01 2300% | 0,05 -0,01 600% | -0,05 | -0,04 | 0,01 | 0,01 | 0,03 | 0,07 |
| Announcement Date | 17/03/25 | 09/05/25 | 14/08/25 | 13/11/25 | 18/03/26 | 13/05/26 | 12/08/26 | - | - | - | - | - | - |
| 31/08/2026 |  | Earnings release - Q2 2026 | |
| 31/08/2026 | | Earnings release - Q2 2026 | |
| 31/08/2026 | | Earnings release - Q2 2026 | |
| 31/08/2026 | | Board of Directors Meeting | |
| 31/08/2026 | | Significant Split/Dividend | 08:00 |
| 31/08/2026 | | Ex-dividend date - 2.56532 TWD | 08:00 |
| 31/08/2026 | | Earnings release - Q2 2026 | |
| 31/08/2026 | | Extraordinary General Meeting | |
| 31/08/2026 | | Présentation aux Actionnaires / Analystes | 07:00 |
| 31/08/2026 | | Board of Directors Meeting |
Past sector events for Protalix Biotherapeutics Inc
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 | |
| 29/08/2026 | | Earnings release - Q2 2026 |
